about
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology...
Read More
66.27
1.96
(3.05%)
1.0M
XNAS Volume
XNAS 09 Jan, 2026 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Arcellx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..